<?xml version="1.0" encoding="UTF-8"?>
<p>Medicinal products are authorized once their quality, safety, and efficacy have been assessed and their benefit‚Äêrisk balance judged to be positive. By supporting the development of new medicines and granting marketing authorizations, Regulatory Authorities (RAs) enable the availability of new therapeutic options to respond to unmet medical needs.
 <xref rid="pds5133-bib-0001" ref-type="ref">
  <sup>1</sup>
 </xref> RAs are responsible for protecting public health by monitoring that the above requirements are met throughout the entire lifecycle of a medicinal product and by taking the necessary actions, when this is no longer the case.
</p>
